Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$148M |
| 2 |
Mondelez International
MDLZ
|
+$144M |
| 3 |
Johnson & Johnson
JNJ
|
+$64.3M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$53.4M |
| 5 |
Microsoft
MSFT
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$225M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$151M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$91.6M |
| 4 |
Walmart Inc
WMT
|
+$87.7M |
| 5 |
JPMorgan Chase
JPM
|
+$79.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 29.71% |
| 2 | Healthcare | 20.65% |
| 3 | Consumer Discretionary | 10.85% |
| 4 | Financials | 7.63% |
| 5 | Technology | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Qorvo
QRVO
$8.74B
| $7.88M | 0.04% |
99,204
-69,108
| -41% | -$6.68M |
|
302
Chegg
CHGG
$102M
| $7.84M | 0.04% |
371,964
-13,689
| -4% | -$284K |
|
303
NXP Semiconductors
NXPI
$60.4B
| $7.78M | 0.04% |
52,764
-25,353
| -32% | -$4.25M |
|
|
LHCG
304
DELISTED
LHC Group LLC
LHCG
| $7.71M | 0.04% |
47,123
-72
| -0.2% | -$11.7K |
|
305
Bunge Global
BG
$20.8B
| $7.67M | 0.04% |
92,907
+68,069
| +274% | +$6.34M |
|
306
Lantheus
LNTH
$6.59B
| $7.51M | 0.04% |
106,756
+72
| +0.1% | +$5.45K |
|
307
BellRing Brands
BRBR
$1.34B
| $7.38M | 0.04% |
358,161
+34,096
| +11% | +$819K |
|
|
FISV
308
Fiserv Inc
FISV
$27.9B
| $7.38M | 0.04% |
78,856
-60,397
| -43% | -$6.15M |
|
309
Brunswick
BC
$5.28B
| $7.37M | 0.04% |
112,549
-28,012
| -20% | -$2.1M |
|
310
Simply Good Foods
SMPL
$982M
| $7.31M | 0.04% |
228,551
-7,472
| -3% | -$245K |
|
311
Dow Inc
DOW
$21.2B
| $7.3M | 0.04% |
166,154
-415,805
| -71% | -$21.1M |
|
312
Globus Medical
GMED
$11.2B
| $7.23M | 0.04% |
121,441
-3,779
| -3% | -$228K |
|
313
Encompass Health
EHC
$12.4B
| $7.21M | 0.04% |
159,314
-44,806
| -22% | -$2.24M |
|
314
TE Connectivity
TEL
$62.6B
| $7.18M | 0.04% |
65,105
+39,416
| +153% | +$4.91M |
|
315
Omnicom Group
OMC
$23.4B
| $7.08M | 0.04% |
112,192
+16,017
| +17% | +$1.09M |
|
316
Agree Realty
ADC
$9.41B
| $6.99M | 0.04% |
+103,354
| New | +$7.77M |
|
317
SBA Communications
SBAC
$19.5B
| $6.96M | 0.04% |
24,465
-5,694
| -19% | -$1.85M |
|
318
Union Pacific
UNP
$174B
| $6.94M | 0.04% |
35,636
-11,786
| -25% | -$2.61M |
|
319
Public Service Enterprise Group
PEG
$37.7B
| $6.84M | 0.03% |
121,699
-134,708
| -53% | -$8.67M |
|
320
American Water Works
AWK
$26.9B
| $6.82M | 0.03% |
52,384
-35,452
| -40% | -$5.34M |
|
321
Flowers Foods
FLO
$1.57B
| $6.77M | 0.03% |
274,124
-185,077
| -40% | -$5M |
|
322
KLA
KLAC
$259B
| $6.75M | 0.03% |
222,880
-36,680
| -14% | -$1.27M |
|
|
THS
323
DELISTED
Treehouse Foods
THS
| $6.72M | 0.03% |
158,369
-8,299
| -5% | -$372K |
|
324
Arthur J. Gallagher & Co
AJG
$63.6B
| $6.72M | 0.03% |
39,222
+34,257
| +690% | +$6.08M |
|
325
Duolingo
DUOL
$6.12B
| $6.68M | 0.03% |
70,133
+10,517
| +18% | +$1.02M |
|
Similar funds
Ray Dalio's Q3 2022 Portfolio in Review
As of Q3 2022, Ray Dalio held 1,045 positions worth $19.8B, down 16% from $23.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ray Dalio withdrew a net $2.53B in Q3 2022, closing 179 positions and reducing 498 holdings. Its most notable exit was Medtronic, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ray Dalio opened a new position in Accenture worth $29.3M.
- Ray Dalio's largest Q3 2022 buy was Accenture: 113,811 shares worth $29.3M.
- Ray Dalio added most to Visa in Q3 2022, an estimated $148M increase.
- Ray Dalio's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $151M.
- Ray Dalio fully exited Medtronic in Q3 2022, selling an estimated $225M.
- Ray Dalio's ten largest holdings make up 32% of its $19.8B portfolio in Q3 2022.
- Ray Dalio opened 60 new positions and closed 179 in Q3 2022.
- Ray Dalio's portfolio value fell 16% quarter-over-quarter to $19.8B.
Based on Bridgewater Associates's 13F filing for Q3 2022, filed 10 Nov 2022.